Louise Lambert

Centre Hospitalier de l’Université de Montréal

Papers

3

Total Citations

59

H-Index

2

About

Dr. Louise Lambert is a leading radiation oncologist whose research has significantly advanced the treatment of early-stage non-small cell lung cancer (NSCLC) through stereotactic body radiotherapy (SBRT). Her work focuses on patient-adapted, robotic SBRT techniques, particularly using the CyberKnife system, to deliver precise, high-dose radiation while minimizing damage to surrounding healthy tissue. In her highly cited 2014 study (33 citations), Dr. Lambert demonstrated excellent cancer outcomes with this approach in 150 patients, but also issued a critical caution for those with idiopathic pulmonary fibrosis, a finding that has shaped clinical guidelines. She further distinguished herself by investigating long-term quality of life in NSCLC survivors treated with robotic stereotactic ablative radiation therapy, providing vital patient-centered evidence. Additionally, her work on breath-hold CT accuracy for treatment planning has improved the precision of lung SBRT delivery. With over 59 citations across her key publications, Dr. Lambert’s research has directly enhanced both the efficacy and safety of lung cancer radiotherapy, establishing her as a thoughtful and impactful voice in the field.

Research Focus

Key Achievements

2
H-Index
3
Papers
59
Total Citations
20
Avg Citations/Paper
🏆 Most Cited Paper
Excellent Cancer Outcomes Following Patient-adapted Robotic Lung SBRT But a Case for Caution in Idiopathic Pulmonary Fibrosis
33 citations · 2014
📈 Most Prolific Year: 2014 (2 Papers)
🤝 Key Collaborators: 17
🏛 Institutions: Centre Hospitalier de l’Université de Montréal

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago